Bezzio et al. (48) named shared susceptibility genes between IBD and MS as a proof of a,common genetic background” and underlined that Th17 cells are an important participant in both diseases, producing pro-inflammatory cytokines (IL-17, IL-22), with high IL-17 levels being found in both pathologies. Here, IL22 is linked to myeloid sarcoma.